VINC
Vincerx Pharma Inc

2,068
Loading...
Loading...
News
all
press releases
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates VINC, MHLD, NEUE on Behalf of Shareholders
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates VINC, MHLD, NEUE on Behalf of Shareholders SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates VINC, MHLD, NEUE on Behalf of Shareholders PR Newswire...
PR Newswire·8mo ago
News Placeholder
More News
News Placeholder
VINCERX PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick and Foti, LLC Investigates Merger of Vincerx Pharma, Inc. - VINC
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed merger of Vincerx Pharma, Inc. (NasdaqCM: VINC) and...
Business Wire·9mo ago
News Placeholder
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates JWN, VINC, OMIC on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates JWN, VINC, OMIC on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates JWN, VINC, OMIC on Behalf of Shareholders...
PR Newswire·9mo ago
News Placeholder
VINC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Vincerx Pharma, Inc. Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Vincerx Pharma, Inc. (NASDAQ: VINC) and Oqory, Inc. is fair to Vincerx shareholders. Upon completion of the...
Business Wire·9mo ago
News Placeholder
Shareholder Alert: Ademi LLP Investigates Whether Vincerx Pharma, Inc. Is Obtaining a Fair Price for Its Public Shareholders
Ademi LLP is investigating Vincerx (Nasdaq: VINC) for possible breaches of fiduciary duty and other violations of law in its transaction with the Oqory. Click here to learn how to join our...
Business Wire·9mo ago
News Placeholder
Vincerx Pharma Stock Rises On Proposed Merger With Oqory: Retail Remains Bullish
Retail sentiment on Stocktwits has remained ‘bullish’ on the stock.
Stocktwits·9mo ago
News Placeholder
Vincerx Pharma Stock Gets Retail Followers Buzzing With Big Layoff Plans To Sustain Cancer Drug Trials
The company's plans include a 55% reduction in force and exploring strategic alternatives such as out-licensing, mergers, or asset sales.
Stocktwits·10mo ago
News Placeholder
Penny Stock Cancer-Focused Vincerx Pharma Seeks Development Partner For 2 Early-Stage Blood Cancer Candidates
Vincerx Pharma announces early results for VIP943 and VIP236 in Phase 1 studies targeting hard-to-treat cancers, with complete responses seen in AML and HR-MDS patients and encouraging disease...
Benzinga·1y ago
News Placeholder
VINC Stock Earnings: Vincerx Pharma Beats EPS for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips VINC stock results show that Vincerx Pharma beat analyst estimates for earnings per share the fourth quarter of 2023. The post VINC...
InvestorPlace·1y ago
News Placeholder
Vincerx to Host Virtual Investor Event Reviewing Preliminary Phase 1 VIP236 Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024
Vincerx to also provide update on pipeline progress, including for VIP943 programPALO ALTO, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical...
Globe Newswire·1y ago

Latest VINC News

View

Advertisement. Remove ads.

Advertisement. Remove ads.